Sorry for the delay in commenting here. Am really busy those days. I have indeed read the news and France decided the same thing as Italy. I have read today an interested comment on the study, claiming that one missing information concerns the dose of medication taken, and that it would be better to provide the information country-related and not continent related as we could have large variation in the healthcare system (among a problem with the sample of people as such, the information being private). The conclusions of the comment was that it would be better not to stop the studies on a country by country basis. I must say I am a bit puzzled but tend to agree with the comment.
You are viewing a single comment's thread from:
In my opinion, there are too many risks and too many uncertainties...when, at the beginning, the patients treated were still too few to give a judgment, it could have made sense to continue. But now that the evidence is clear, I think it's better to leave it and continue on other solutions, which instead have proved more valid.
In the meantime, it seems less and less clear (cf. the message from the editor of yesterday). The issues that are raised are exactly those.
When science and politics mix with each other, some actions may be done too hastily... We need the studies to understand more.